Church Biomedical Inc is categorized under Hospital Equipment Repair and Refinishing in Greensboro, NC and active since 1989.
Church Biomedical Inc was established in 1989, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Hospital Equipment Repair and Refinishing business, which does work in the B2C market, and is classified as a Hospital Equipment Repair and Refinishing, under code number 811219 by the NAICS.
If you are seeking more information, feel free to contact Roy Church at the company’s single location by writing to 801 1/2 Summit Avenue A, Greensboro, North Carolina NC 27405 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Church Biomedical Inc |
Contact Person: | Roy Church |
Address: | 801 1/2 Summit Avenue A, Greensboro, North Carolina 27405 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1989 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Hospital Equipment Repair and Refinishing |
SIC Code: | 7699 |
NAICS Code: | 811219 |
Share This Business: |
Church Biomedical Inc was started in 1989 to provide professional Hospital Equipment Repair and Refinishing under the SIC code 7699 and NAICS code 811219. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Roy Church for inquiries that concern Church Biomedical Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Church Biomedical Inc can be found at the coordinates 36.082275,-79.778528 as well as the street address 801 1/2 Summit Avenue A in Greensboro, North Carolina 27405.
For its online presence, you may visit Church Biomedical Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.